Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03728348 · ClinicalTrials.gov registry record
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 983
- Enrollment target
NCT03728348 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 983 participants.
The verdict
NCT03728348 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 983 participants
- Enrollment target
Study Summary
The primary objective is to confirm the specificity of a multi-target stool DNA test (mt-sDNA), Cologuard, in an average risk population, ages 45-49.
Interventions
- PROCEDURE Colonoscopy
- DIAGNOSTIC_TEST mt-sDNA screening test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 983 participants |
| Start Date | 2018-11-06 |
| Est. Completion | 2019-06-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03728348
The ClinicalTrials.gov registry entry for NCT03728348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 983 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Colonoscopy is the first listed.
NCT03728348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03728348 about?
NCT03728348 is a clinical study titled "An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now". The primary objective is to confirm the specificity of a multi-target stool DNA test (mt-sDNA), Cologuard, in an average risk population, ages 45-49.
What is the current status of trial NCT03728348?
This trial is currently completed. The enrollment target is 983 participants. The study started on 2018-11-06. Estimated completion is 2019-06-18.
What interventions are being tested in trial NCT03728348?
The interventions under investigation include: Colonoscopy (PROCEDURE), mt-sDNA screening test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03728348?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.